Immunologic Control of Mus musculus Papillomavirus Type 1

Agriculture & Biology

• Papillomaviridae 100%
• Mus musculus 79%
• T-lymphocytes 65%
• papilloma 53%
• mice 33%
• antibodies 30%
• capsid 15%
• infection 10%
• immunogenetics 9%
• calreticulin 9%
• immunotherapy 8%
• DNA 6%
• epitopes 6%
• in situ hybridization 6%
• vaccination 5%
• tail 5%
• skin (animal) 4%
• cell lines 4%
• breeds 4%
• genomics 4%
• dosage 3%
• animals 2%

Medicine & Life Sciences

• Papilloma 50%
• T-Lymphocytes 44%
• Inbred C57BL Mouse 27%
• Antibodies 23%
• Capsid 16%
• Infections 10%
• Calreticulin 10%
• Immunogenetics 9%
• T-Lymphocyte Epitopes 8%
• Adoptive Transfer 8%
• DNA 8%
• Tail 6%
• Knockout Mice 6%
• In Situ Hybridization 6%
• Immunotherapy 6%
• Anti-Idiotypic Antibodies 6%
• Vaccination 5%
• Cell Line 4%
• Polymerase Chain Reaction 4%
• Recurrence 4%
• Skin 3%
• Animals 3%
• Therapeutics 1%